Access this stock data via API
Subscribe
Sinopharm Group Co., Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date Mar 2024 Sep 2023 Dec 2022 Sep 2022
Total reported revenue 145.0B 145.8B 144.9B
Cost of revenue
Gross profit
Operating expense
Research & development
Selling general and admin 5.7B 7.8B 5.7B
Other operating expenses 411.7B
Operating income 5.0B 7.1B 5.7B
Non operating interest income
Income
Expense 367.0M 1.3B 449.6M
Other income expense
Pretax income 4.2B 6.0B 4.6B
Tax provision 987.1M 1.4B 1.0B
Net income 3.2B 4.5B 3.6B
Basic EPS 0.5
Diluted EPS 0.5
Basic average shares 3.4B
Diluted average shares 3.4B
EBITDA 4.3B 8.5B 5.0B
Net income from continuing op.
Minority interests -1.2B -1.9B -1.4B
Preferred stock dividends 0 0 0
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 11 hours 12 minutes

21:47
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).